Luyendyk J, Schoenecker J, Flick M
Blood. 2018; 133(6):511-520.
PMID: 30523120
PMC: 6367649.
DOI: 10.1182/blood-2018-07-818211.
Rimmer E, Houston B, Kumar A, Abou-Setta A, Friesen C, Marshall J
Crit Care. 2014; 18(6):699.
PMID: 25527094
PMC: 4318234.
DOI: 10.1186/s13054-014-0699-2.
Harr J, Moore E, Johnson J, Chin T, Wohlauer M, Maier R
Crit Care Med. 2012; 41(2):399-404.
PMID: 23263579
PMC: 3557727.
DOI: 10.1097/CCM.0b013e31826ab38b.
Gao J, Hu Z, Zhao Z, Liu G, Ren Y, Chen G
Protein J. 2011; 30(8):521-8.
PMID: 21959792
DOI: 10.1007/s10930-011-9357-6.
Flick M, Chauhan A, Frederick M, Talmage K, Kombrinck K, Miller W
Blood. 2011; 117(23):6326-37.
PMID: 21436072
PMC: 3122951.
DOI: 10.1182/blood-2010-08-304915.
Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells.
Li Y, Du B, Pan J, Chen D, Liu D
J Zhejiang Univ Sci B. 2006; 7(11):899-905.
PMID: 17048305
PMC: 1635816.
DOI: 10.1631/jzus.2006.B0899.
Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition.
Hoffmann J, Vollmar B, Laschke M, Fertmann J, Jauch K, Menger M
Crit Care. 2005; 9 Suppl 4:S33-7.
PMID: 16168073
PMC: 3226166.
DOI: 10.1186/cc3758.
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.
Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G
Gut. 2005; 54(5):718-25.
PMID: 15831923
PMC: 1774473.
DOI: 10.1136/gut.2004.038679.
Interactions between the innate immune and blood coagulation systems.
Esmon C
Trends Immunol. 2004; 25(10):536-42.
PMID: 15364056
PMC: 7185622.
DOI: 10.1016/j.it.2004.08.003.
Pharmacoeconomic implications of new therapies in sepsis.
Wood K, Angus D
Pharmacoeconomics. 2004; 22(14):895-906.
PMID: 15362927
DOI: 10.2165/00019053-200422140-00001.
Coagulation in sepsis.
Amaral A, Opal S, Vincent J
Intensive Care Med. 2004; 30(6):1032-40.
PMID: 15148567
DOI: 10.1007/s00134-004-2291-8.
Sepsis and disseminated intravascular coagulation.
Levi M, de Jonge E, van der Poll T
J Thromb Thrombolysis. 2004; 16(1-2):43-7.
PMID: 14760211
DOI: 10.1023/B:THRO.0000014592.27892.11.
[Activated protein C. Inevitable in sepsis?].
Max M
Anaesthesist. 2004; 52 Suppl 1:S32-9.
PMID: 14727049
DOI: 10.1007/s00101-003-0592-x.
Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery.
Boldt J, Ducke M, Kumle B, Papsdorf M, Zurmeyer E
Intensive Care Med. 2004; 30(3):416-22.
PMID: 14712346
DOI: 10.1007/s00134-003-2110-7.
Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.
de Jonge E, Friederich P, Vlasuk G, Rote W, Vroom M, Levi M
Clin Diagn Lab Immunol. 2003; 10(3):495-7.
PMID: 12738659
PMC: 154959.
DOI: 10.1128/cdli.10.3.495-497.2003.
Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis.
Opal S, Esmon C
Crit Care. 2003; 7(1):23-38.
PMID: 12617738
PMC: 154114.
DOI: 10.1186/cc1854.
Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.
Nagashima M, Yin Z, Zhao L, White K, Zhu Y, Lasky N
J Clin Invest. 2002; 109(1):101-10.
PMID: 11781355
PMC: 150816.
DOI: 10.1172/JCI12119.
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.
Riewald M, Ruf W
Proc Natl Acad Sci U S A. 2001; 98(14):7742-7.
PMID: 11438726
PMC: 35412.
DOI: 10.1073/pnas.141126698.
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E, Huang W, Coughlin S
Proc Natl Acad Sci U S A. 2000; 97(10):5255-60.
PMID: 10805786
PMC: 25815.
DOI: 10.1073/pnas.97.10.5255.
